A Family Meeting Unites Families and Researchers

More than 40 researchers and over 200 members of the AHC community came together in Boston this weekend for the Cure AHC Family Meeting, hosted in partnership with RARE Hope and For Henry AHC.

The meeting was built around two parallel tracks. Researchers spent the weekend advancing the science that will shape the next generation of AHC therapies, while families participated in educational presentations, workshops, and discussions designed to better understand the rapidly changing therapeutic landscape and connect with one another. But the most important moments happened when those two tracks came together.

Throughout the weekend, scientists presented their work directly to families, answered questions, and listened carefully to the lived experience of patients and caregivers. Families, in turn, helped researchers better understand the realities of living with AHC, the symptoms that matter most, and what meaningful improvement would look like in everyday life. Those conversations are not a side benefit of the meeting—they are an essential part of how better therapies are developed.

Two scientific workshops highlighted this year's meeting. The first brought together researchers developing new therapeutic strategies for AHC, with a particular focus on drug repurposing and strengthening the pipeline of therapies moving toward the clinic. The second focused on one of the most important questions facing the field: how should success be measured in future clinical trials? Researchers, clinicians, and families worked together to define clinically meaningful endpoints that reflect the symptoms and outcomes that matter most to patients.

For families, the meeting offered something equally important.

For many children with AHC, it is one of the few opportunities to spend time with other children just like them. Friendships are formed that continue long after the meeting ends. For families, the experience can be powerful. Parents find themselves surrounded by people who already understand the language of episodes, hospitalizations, uncertainty, medical emergencies, behavioral challenges, the impact on siblings, and the countless challenges — and joys — that come with raising a child with AHC.

For researchers, there is no greater reminder of why this work matters than spending time with the children and families they are trying to help. The science may begin in the laboratory, but its purpose becomes tangible when researchers see children laughing together, families supporting one another, and a community united by hope and determination. Those moments are often the inspiration that carries the work forward long after the meeting ends.

Progress in rare disease depends on partnerships like these. Scientific discovery, clinical research, and patient experience each contribute something essential. When they come together, they create an ecosystem capable of moving discoveries toward treatments faster than any one group could accomplish alone.

The Boston Family Meeting demonstrated exactly what makes the AHC community so extraordinary: researchers committed to patients, families committed to science, and a shared belief that together we can change the future of this disease.